MediPharm Labs Corp. announced that its has entered into an initial three-year extraction agreement for processing of dried cannabis to cannabis oil concentrates with TerrAscend Corp. This Agreement marks a strong start to 2019 for MediPharm as the Company continues to grow its base of multi-year cannabis extraction and processing customers, increasing asset utilization and recurring revenue expectations. Under the terms of the Agreement, TerrAscend will supply bulk quantities of dried cannabis to MediPharm for processing on a fee for service basis into bulk resin or other premium cannabis oil derivative products sold under TerrAscend brands.